Stith, Briana J.
Buls, Samantha M.
Keim, Sarah A.
Thung, Stephen F.
Klebanoff, Mark A.
Landon, Mark B.
Gabbe, Steven G.
Gandhi, Kajal K.
Oza-Frank, Reena
Funding for this research was provided by:
American Diabetes Association (1-18-JDF-062)
Article History
Received: 11 March 2021
Accepted: 20 May 2021
First Online: 29 June 2021
Declarations
:
: The study was approved by Nationwide Children’s Hospital’s Institutional Review Board (IRB #18-00178), and the study has a reliance agreement with the Ohio State University Wexner Medical Center. Informed consent takes place in private at 30–40 weeks’ gestation or 7–14 days postpartum during Visit 1. Consent obtained from study participants was initially written consent but was approved by the IRB to also be verbal when in-person visits were limited (starting March 2020 due to the COVID-19 pandemic).
: Not applicable.
: The authors declare that they have no competing interests.